NYSE: HAE
Haemonetics Corp Stock Ownership - Who owns Haemonetics?

Insider buying vs selling

Have Haemonetics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mark W. KrollDirector2025-11-101,400$70.56
$98.78kBuy
Roy GalvinEVP Chief Commercial Officer2025-10-31145$50.01
$7.25kSell
Laurie A. MillerSVP Human Resources2025-09-17238$49.95
$11.89kSell
Christopher SimonPresident CEO2025-05-3026,234$69.38
$1.82MSell
Michelle L. BasilEVP and General Counsel2025-05-307,469$69.38
$518.20kSell
James DareccaEVP Chief Financial Officer2025-05-305,864$69.38
$406.84kSell
Laurie A. MillerSVP Human Resources2025-05-302,283$69.38
$158.39kSell
Christopher SimonPresident CEO2025-05-167,089$70.31
$498.43kSell
Laurie A. MillerSVP Human Resources2025-05-16477$70.31
$33.54kSell
Roy GalvinPresident Global Plasma BC2025-05-16257$70.31
$18.07kSell

1 of 2

HAE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when HAE insiders and whales buy or sell their stock.

HAE Shareholders

What type of owners hold Haemonetics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc12.86%6,020,678$484.06MInstitution
Vanguard Group Inc10.33%4,834,646$388.71MInstitution
Neuberger Berman Group LLC7.84%3,670,282$295.09MInstitution
Aqr Capital Management LLC4.55%2,128,878$171.16MInstitution
State Street Corp3.85%1,800,729$144.78MInstitution
River Road Asset Management LLC3.54%1,654,790$133.05MInstitution
Ubs Group Ag3.10%1,452,571$116.79MInstitution
Royal Bank Of Canada2.69%1,260,820$101.37MInstitution
Fmr LLC2.60%1,215,829$97.75MInstitution
Geode Capital Management LLC2.57%1,203,380$96.75MInstitution

1 of 3

HAE vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HAE97.09%2.91%Net SellingNet Buying
ICUI72.01%27.99%Net BuyingNet Selling
NNNN0.05%0.00%
NVST63.78%36.22%Net SellingNet Selling
WRBY54.28%45.72%Net SellingNet Selling

Haemonetics Stock Ownership FAQ

Who owns Haemonetics?

Haemonetics (NYSE: HAE) is owned by 109.63% institutional shareholders, 3.28% Haemonetics insiders, and 0.00% retail investors. Blackrock Inc is the largest individual Haemonetics shareholder, owning 6.02M shares representing 12.86% of the company. Blackrock Inc's Haemonetics shares are currently valued at $488.34M.

If you're new to stock investing, here's how to buy Haemonetics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.